Oklahoma's Medical Cannabis Laws & Regulations
In April of 2015 Gov. Fallin signed HB 2154, Katie and Cayman's Law, which allows physicians in Oklahoma to recommend a clinical trial with high-CBD cannabis oil (less than .3% THC) to minors suffering from a severe epilepsy disorder like Lennox-Gastaut Syndrome or Dravet Syndrome. The trial is to be administered at University medical centers. The bill makes no allowance for the production, distribution or analysis of the CBD oil. Presumably patients are supposed to illegally bring CBD oil from another state.
HB 2835 (2016) - expansion of protections